CN Patent

CN108137516A — 奥扎莫德的晶型、其制备方法及药物组合物

Assigned to Solipharma LLC · Expires 2018-06-08 · 8y expired

What this patent protects

本发明涉及奥扎莫德的晶型，与已知的奥扎莫德相比，本发明的奥扎莫德晶型具有一种或多种改进的特性。本发明还涉及奥扎莫德晶型的制备方法、其药物组合物及其用于制备在医学上需要选择性鞘氨醇‑1‑磷酸酯受体的调节、活化、激动、抑制或拮抗的病症或不良状况的药物中的用途。

USPTO Abstract

本发明涉及奥扎莫德的晶型，与已知的奥扎莫德相比，本发明的奥扎莫德晶型具有一种或多种改进的特性。本发明还涉及奥扎莫德晶型的制备方法、其药物组合物及其用于制备在医学上需要选择性鞘氨醇‑1‑磷酸酯受体的调节、活化、激动、抑制或拮抗的病症或不良状况的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN108137516A
Jurisdiction
CN
Classification
—
Expires
2018-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Solipharma LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.